Oregon Drug Discovery Symposium
The deadline to register is April 5th
Learn more and register in the Registration dropdown below.
Connect with the drug discovery community!
Welcome to the Oregon Drug Discovery Symposium (ODDS). This event offers a unique opportunity for all members of the drug discovery community – including researchers, pharmaceutical companies, investment groups, academia, and the broader biomedical community – to share ideas and innovations. We anticipate days of exciting talks and discussions, including a poster session. We look forward to welcoming you to OHSU for ODDS 2026.
— Sanjay V. Malhotra, Ph.D., Director, OHSU Center for Experimental Therapeutics
Save the date: April 8-9, 2026
Knight Cancer Research Building
2720 S. Moody Ave.
Portland, OR 97201
A virtual option will be available.
-
Additional participants will be added as they are confirmed.
Nabil J. Alkayed, M.D., Ph.D. – Oregon Health and Science University
Philip Barish, Ph.D. - Oregon Health and Science University
Connor Barth, Ph.D. - Trace Biosciences, Co-founder and CEO
Danielle Benoit, Ph.D. – University of Oregon
Robert Brown – The Answer Project, Senior Partner
Shweta Chavan, Ph.D. – Pathomiq, Principal Scientist
David A. Dorr, M.D., M.S. – Oregon Health and Science University
Brian Druker, M.D. – OHSU Knight Cancer Institute, CEO
Robert Eil, MD, Oregon Health and Sciences University
Shereef Elnahal, M.D., M.B.A – Oregon Health and Science University, President
David Farrell, Ph.D., F.A.H.A - Oregon Health and Science University, Gamma Therapeutics Inc, Founder and CSO
Marc R. Freeman, Ph.D. - Oregon Health and Science University, Vollum Institute Director
Mary M. Heinricher, Ph.D. - Oregon Health and Science University
Laura M. Heiser, Ph.D. - Oregon Health and Sciences University
Joe Horsman – Madrona, Investor
Janani Iyer Ph.D. – Absci, Head of AI/ML Products
Nathalie McDowell Johnson, M.D., FACS – Legacy Medical Group, Oregon
Felix Kim – Next Ventures, Principal
David M. Lewinsohn, M.D., Ph.D., Oregon Health and Sciences University
Min Lu, Ph.D. - Ruijin Hospital, Jiao Tong University, China
Aditi Martin, Ph.D. – OHSU, Senior Director of Collaborations and Entrepreneurship
Ahmad Masri, M.D., M.S. - Oregon Health and Science University
Bonnie Nagel, Ph.D. - Oregon Health and Science University
Ben Nahir, Ph.D., M.B.A - Elevate Capital, Partner
Rohan Palekar – CEO of 89bio, Inc. and Freelance Investor
Angelica Parente, Ph.D. - Civilization Ventures, Operating Partner
Michael C. Phillips – Davis Wright Tremaine LLS, Partner
Ahmed M. Raslan, M.D., FAANS - Oregon Health and Science University
Eric Roeland, M.D., FAAHPM, FASCO - Oregon Health and Sciences University
Thomas S. Scanlan, Ph.D. - Oregon Health and Science University
Nathan R. Selden, M.D., Ph.D., FACS, FAAP – Dean, OHSU School of Medicine
Divya Sood, M.D. - Oregon Health and Sciences University
Rebecca Spain, MD, MSPH, Oregon Health and Science University
Matthew Taylor, MD, Earle A. Chiles Research Institute, Providence
Phillip R. Torralva, M.D. – TMT Rx, Founder, CEO and CSO
Andrew Weinberg, PhD, Earle A. Chiles Research Institute, Providence
Rachel Wolters, D.V.M., Ph.D. – OHSU Oregon National Primate Research Center
Wassana Yantasee Ph.D. - Oregon Health and Sciences University
-
You will receive an email from EventBrite containing your ticket and registration information. Please save this email for future reference and to show at registration. If you are on the waitlist or register to attend virtually, you will receive an email but will not receive a ticket. If you have questions about your registration, please email CET@ohsu.edu.
2026 Registration Rates
Academia / Non-profit $100 Industry $250 Virtual Attendance $25 Trainees / Students $50 -
Thank you for the strong interest in ODDS 2026. Abstract submission is now closed, and the poster session is at capacity.
The abstract submission deadline has been extended to March 15th, 2026. Participants must submit by the deadline to be considered for the poster competition. Poster presentations will not be available to virtual participants. If you are presenting a poster, you must also register for the conference.
Abstract submission deadline may be extended based on availability.
General information:
- Poster size should be no larger than 48 inches x 48 inches (122 cm x 122 cm). A 36 in x 48 in poster (in landscape or portrait orientation) is a common size.
- Abstracts are limited to 2500 characters, including spaces.
- Please proofread your abstract carefully for spelling and data errors. Pay special attention to the author order and the presenting author designation
-
To discuss conference sponsorship or for sponsorship questions, please contact: CET@ohsu.edu
Sponsorship Tiers
Core Sponsor - $10,000
Premier sponsor benefits plus choice of 2 Add-On Opportunities from the list below.Premier Sponsor — $5,000
6 sponsorships at this level- Preferred 6’ exhibitor table located near the main session hall and refreshment area.
- Entry for two (2) representatives.
- Company logo and 100-word profile in the event program and on the symposium website.
- Recognition in opening and closing remarks.
- Acknowledgment on event signage and welcome slides.
Poster Sponsor — $3,000
10 sponsorships at this level- Poster in industry poster space.
- Entry for two (2) representatives.
- Company logo listed in the event program and website.
- Recognition in opening remarks.
Non-Exhibiting Industry Participant — $250
- Entry for one (1) representative (no exhibit table).
- Company name listed in the event program.
Add-On Opportunities
For enhanced visibility- Breakfast Sponsor – $750
Logo signage at refreshment stations and acknowledgment during remarks.
- Coffee Break Sponsor – $500
Logo signage at refreshment stations and acknowledgment during remarks.
- Lunch Sponsor – $1,000
Logo signage at refreshment stations and acknowledgment during remarks.
- Reception Sponsor – $750
Logo signage at refreshment stations and acknowledgment during remarks.
- Dinner Sponsor – $2,000
Logo signage at refreshment stations and acknowledgment during remarks.
- Trainee Travel Support – $1,500
Recognition in program and signage for supporting trainee attendance.
-
Venue
The 2026 symposium will be held at the Knight Cancer Research Building.
Accommodations
Downtown Portland has many hotels and lodging options conveniently connected by light rail, Portland street car, and bus lines.
The recommended hotel for the conference is the Hyatt House Portland Downtown. The hotel is conveniently located 0.3 miles from the venue, within easy walking distance.
Hyatt House Portland Downtown
2080 SW River Drive
Portland, OR 97201
503-241-2775
MapAdditional lodging options include:
Local Transportation
The symposium venue is just south of downtown Portland, Oregon, and easily accessible by the Portland Streetcar and MAX light rail. This makes most downtown Portland hotels a convenient choice for conference accommodations.
Parking
Limited parking will be available at the Schnitzer Parking Lot, located next to the Knight Cancer Research Building. Kiosks are located in the lot to pay for parking with a credit card.
-
Pictured (left-to-right): Dr. Sanjay Malhotra, Dr. Annah Rolig, Denise Hopkins, Dr. Shivaani Kummar. Sanjay V. Malhotra, PhD, FRSC
Sheila Edwards-Lienhart Chair in Cancer Research
Professor, Department of Cell, Development & Cancer Biology
Director, OHSU Center for Experimental Therapeutics
Director, OHSU Center for Radiochemistry ResearchShivaani Kummar, M.D., FACP
Associate Chief Executive Officer, OHSU Knight Cancer Institute
Margaret and Lester DeArmond University Chair of Molecular Oncology, Medicine, Division of Hematology/Medical Oncology, OHSU School of Medicine
Co-Director, Center for Experimental Therapeutics, OHSU Knight Cancer InstituteAnnah Rolig, Ph.D.
Senior Scientist, Center for Experimental Therapeutics, OHSUDenise Hopkins
Program Administrator, Center for Experimental Therapeutics, OHSU
Premier Plus Sponsor
Premier Sponsor
Supporting Sponsor
Archive
-
2025 Oregon Drug Discovery Symposium
On April 9, 2025, the OHSU Center for Experimental Therapeutics (CET) hosted the inaugural Oregon Drug Discovery Symposium (ODDS) at the Knight Cancer Institute. The symposium drew over 350 attendees from across the country, including researchers, start-ups, and investors.